Meet the MOPEAD Team!


We are excited to announce that the next occasion to meet the MOPEAD team is at the 27th Alzheimer Europe Conference, being held in Berlin from 2-4 October. MOPEAD will be represented on 4 October, at a symposium convened by Eli Lilly, entitled: “Engaging with patient organisations within IMI consortia to inform quality, relevance and value in Alzheimer’s research – insights from MOPEAD, EPAD and ROADMAP”.


The symposium will explore how these three initiatives are tackling Alzheimer’s disease across the disease continuum. The panellists will provide their perspectives regarding the rationale for each project, engaging in a discussion on the concrete multipronged actions to improve timely diagnosis through citizens’ participation, pioneering novel approaches to clinical trials and providing evidence regarding the value of new medications.

Find out more about the conference

Share on Facebook
Share on Twitter
Please reload

Please reload

Please reload

Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations